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Abstract
Background: Adult mammalian tissues heal injury to the skin with formation of scar; this process quickly seals an
injured area, however, excessive scar formation can become a source of persistent pathology, interfering with
multiple vital functions. In contrast, mammalian fetal tissue can heal without scar formation. We previously sought
to model scarless healing in a rabbit fetal skin wound and identified gene products differentially expressed during
fetal wound healing through PCR suppression subtractive hybridization (PCR SSH). One of these transcripts,
previously identified simply as clone 11, showed putative increased expression in wounded fetal skin. This study
establishes its identity as Ero1L-alpha and confirms its elevated expression in healing fetal wounds.
Findings: After obtaining further sequence by 5’ rapid amplification of cloned ends (RACE) we find that clone 11 is
Ero1L-alpha. We determined that clone 11, a differentially expressed transcript in fetal wound healing, comprises
the 3’ untranslated region (UTR) of an approximately 4 kb transcript in rabbit tissues that corresponds to Ero1L-
alpha. We showed that Ero1L-alpha is expressed predominantly as two transcripts in rabbit skin, namely a 1.6 kb
transcript and the 4.0 kb transcript recovered in our PCR SSH screen via its 3’ UTR sequence. However, a third
transcript of 2.9 kb was also detected in Northern blots and was subsequently cloned and confirmed by 3’ RACE.
Knockdown of the clone 11 sequence in rabbit adult fibroblasts via siRNA resulted in significantly decreased Ero1L-
alpha message expression. Increased expression of clone 11 (Ero1L-alpha) in a variety of cell types during the
wound healing response was also confirmed by in situ hybridization.
Conclusions: Ero1L-alpha is one of the previously unknown clones identified in a PCR SSH screen for genes
differentially expressed in fetal wounded tissue. In situ hybridization confirms that Ero1L-alpha shows increased
expression in multiple cell types after wounding of the fetal integument.
Introduction
Mammalian skin has multiple critical functions includ-
ing providing homeostasis and serving as a first line of
defence against infection. When injury to the skin
occurs, a complex series of processes initiate its repair
[1,2]. Adult (postnatal) mammals heal injury to the skin
with attendant scar formation [3-5]; this process quickly
seals an injured area, but excessive scar formation can
become a source of persistent pathology and can inter-
fere with numerous vital functions. In contrast, mamma-
lian fetal skin can heal without scar formation. Much
research has focused on identifying the mechanisms
underlying scarless fetal wound repair; these experi-
ments have primarily compared adult and fetal wound
healing by examining various growth factors/cytokines,
extracellular matrix proteins, and chaperonins [6-13].
To date, no specific critical pathways determinative for
scarless repair have been established.
We have previously examined scarless wound healing
in fetal skin by incisional wound modelling in rabbits
[14]. Using PCR suppression subtraction hybridization
(PCR SSH) we identified transcripts exhibiting differen-
tial expression during the fetal wound healing response.
Because PCR SSH compares two conditions across the
entire expressome and recovers only fragments of gene
products, numerous genes of unknown identity and/or
function were recovered. One of the unidentified gene
products, designated clone 11, was upregulated in pooled
samples of fetal wounded tissue samples 12 hours post-
wounding when compared to fetal unwounded control
skin tissue. Herein, we present evidence identifying this
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expression with in vivo studies.
Materials and methods
Source Tissues and Fibroblast Culture
All animal protocols were reviewed and approved by
the Institutional Animal Care and Use Committee
(IACUC); details of animal sample collection were as
described in Kathju et al [14]. ~1 cm incisional
wounds were placed on the dorsums of fetal rabbits at
20-21 days gestation, then harvested 8 days later (as
well as unwounded fetal control skin). For in situ
hybridization studies, fetal wounded and unwounded
control tissues were stored in 10% Neutral Buffered
Formalin (up to 7 days) before embedding; processing,
paraffin embedding, and sectioning of samples were
performed by Research Histology Services (Pittsburgh,
PA) using standard conditions.
For fibroblast culture, samples of unwounded control
skin were obtained from adult and fetal rabbits and
were minced into small pieces within 30 minutes after
dissection. The tissue samples were washed extensively
in PBS containing 1X antibiotic/antimycotic solution
(containing penicillin, streptomycin, and amphotericin
B; Invitrogen Corporation, Carlsbad, CA) and then
placed in RPMI 1640 medium (Invitrogen) containing
10% fetal bovine serum (FBS, Gemini Bio-Products) and
1× antibiotic/antimycotic solution (Invitrogen). The cul-
tures were left undisturbed for 7 days in a 37°C incuba-
tor containing 5% CO2 supplement. The fibroblast
outgrowths observed after a week from primary cultures
were sub-cultured immediately using 0.5% Trypsin
EDTA (Invitrogen). Once the cells reached 90% conflu-
ence, they were either: 1) passaged once more before
total RNA was isolated from passage three adult and
fetal fibroblasts, or 2) plated onto 6-well plates, trans-
fected with 100 μM siRNA (sequences in Table 1) and 4
μl Lipofectamine 2000 (Invitrogen) as previously
described [15], and grown for 2 days before purification
of total RNA.
RNA extraction/purification of samples
For all tissue culture RNA purifications, total RNA was
obtained using the RNeasy Micro Kit (Qiagen Inc. USA,
Valencia, CA) following manufacturer’s protocols with a
DNase treatment step. The quality of total RNA extracted
from fetal and adult tissue and fibroblasts was examined
by capillary electrophoresis using an Agilent 2100 Bio
Analyzer (Agilent Technologies Inc., Palo Alto, CA), and
the quantity determined using the OD260/OD280 ratio
measured using a ND-1000 spectrophotometer (Nanodrop
Technologies Inc., Wilmington, DE).
Table 1 Primers, probes, siRNAs used
Primer Number/Name
(from Figure 2A, if applicable)
Direction Primer Sequence
1 F TCAGCCAGTGTGGAAGGAGGGA
2 F AGGAGACGCAGAAGGCTGTTC
3 F TTGGGTTGTTTTGGTGGTAGAAAGGT
4 F GCCGACAGTCAGCAAGTTTGCTTTATC
5 F GCAGGGCTTGTGGATGTAATGTG
6 R CTGATGTCATTCCAGAAAGGAC
7 R TAACAGCACAGTCCCTCCTTCCACAC
8 R TCAGAGCAGTACCCAAACCCTG
9 R CGGAACAGCAATGGAGTTGGTAAG
clone11 siRNA sense rGrUrGrCrUrArCrArCrArGrArCrCrUrGrUrCrUTT
clone11 siRNA antisense rArGrArCrArGrGrUrCrUrGrUrGrUrArGrCrArCTT
scrambled siRNA sense rUrGrCrGrArUrArCrGrArCrArUrCrCrUrCrGrUTT
scrambled siRNA antisense rArGrUrArCrCrUrGrCrUrGrGrGrUrCrArGrArATT
Ero1LA real time for F ACCTGAAGAGGCCTTGTCCTTT
Ero1LA real time rev R TCCATCAGGAACTTCATCAGATTG
Ero1LA real time probe P TGGAATGACATCAGCCAGTGTGGAAG
clone11 real time for F CTCTGAAAACATGACTCCCTCCTT
clone11 real time rev R AGGAGTCTGGCTTTCTCCTGAA
clone11 real time probe P CACCGCTCTGTGACCTCCTGAAC
GAPDH real time for F CTCTGAAAACATGACTCCCTCCTT
GAPDH real time rev R CCTCGGTGTAGCCCAGGAT
GAPDH real time probe P AAGCAGGCATCCGAGGGCCC
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Rapid amplification of cloned ends (RACE) was used to
obtain 3’ UTR sequence for the various Ero1L-alpha
clones. The GeneRacer kit with AMV reverse transcrip-
tase (Invitrogen) was used for 3’ RACE following manu-
facturer’sd i r e c t i o n s ;2μg of total RNA from fetal
control skin was used as thes o u r c eR N A .A l ls u b s e -
q u e n tP C Rw a sd o n eu s i n gt h eA c c u P r i m eH FP C R
system (Invitrogen) and using the primers listed in
Table 1 following manufacturer’s directions. Cloned
amplimers from RACE reactions were then sequenced.
Primers for Ero1L-alpha were designed from the
predicted rabbit sequence for Ero1L-alpha (ENSO-
CUG00000012632) from Ensembl [16] and primers for
G A P D Hw e r ed e s i g n e df r o mt h eN C B Ir a b b i tG A P D H
sequence (NM_001082253) [17].
DIG RNA probes
DNA constructs for DIG RNA probes were prepared by
either DNA digests of plasmids bearing subcloned
inserts or by direct PCR of cloned and sequenced
probes; DNA templates were gel extracted before use.
DIG RNA probes were prepared using the DIG RNA
labelling kit (Roche, Indianapolis, IN) and T3 RNA Poly-
merase (Promega Corporation, Madison, WI). RNA was
purified using the RNeasy Micro Kit (Qiagen) following
manufacturer’s protocols.
Northern blot
Northern blots were either commercially prepared
(Zyagen, San Diego, CA) or prepared using passage
three fetal and adult fibroblast RNA. Northern blots
were prepared using reagents from the NorthernMax
kit (Applied Biosystems/Ambion, Austin, TX) and with
the NorthernMax Loading Dy ew i t h o u te t h i d i u mb r o -
mide. Total RNA was used as the source for preparing
mRNA using the Oligotex kit (Qiagen). 100 nanograms
of mRNA and RNA marker (Invitrogen) were sepa-
rated on 1% denaturing formaldehyde gels and trans-
ferred to a positively charged nylon membrane
(Roche). RNA was cross-fixed to the membrane using
a UV light box (SpectroLinker XL-1000, optimal cross-
link settings).
Blots were rinsed with DEPC-treated water, and then
prehybridized in DIG EasyHyb buffer (Roche) following
manufacturer’s protocol. Blots were hybridized overnight
at 68°C in DIG EasyHyb with 100 ng DIG-labeled probe.
Blots were washed for two 5 minute low stringency
washes in 2 × SSC, 0.1% SDS at room temperature
followed by two 20 minute high stringency washes in
0.2 × SSC, 0.1% SDS at 68°C. All blocking, washing and
detection of DIG were done with the DIG wash and
Block kit (Roche) and CDP-Star (Roche) following
manufacturer’s protocols.
Quantitative real time RT-PCR
The primer sets for rabbit clone 11 and rabbit Ero1L-
alpha were designed using the initial sequence for clone
11 obtained by PCR SSH, plus additional sequence
obtained through 5’ RACE and 3’ RACE, as well as the
predicted rabbit sequence for Ero1L-alpha (ENSO-
CUG00000012632) from Ensembl [16]. The Taqman
primers/probes reported in Table 1 were designed using
Primer Express software (Applied Biosystems, Foster
City, CA). Initial RT-PCR assays on 100 ng of fetal
unwounded control RNA were used to verify that each
of the primer sets was detectable in fetal tissue and
resulted in only a single amplicon of the expected mole-
cular weight. Primer sequences for the rabbit GAPDH
(used as an internal control)w e r ep r e v i o u s l yp u b l i s h e d
[14]. All primers and fluorocoupled Taqman probes
were purchased from Integrated DNA Technologies
(Coralville, IA).
100 ng of total RNA from samples was used for
reverse transcriptase (RT) reaction (using gene-specific
reverse primer and 10 μl of total volume); for subse-
quent real time PCR assays, 1.5 μL of RT reaction, 800
nM of each primer, and 160 nM of the appropriate
probe (final concentrations) in a total volume of 15 μl
were used. The remaining protocol parameters for RT
reaction and real time PCR were followed as previously
described [14]. Using the comparative critical cycle (Ct)
method and using GAPDH as the endogenous control,
the expression levels of the target genes were normal-
ized and the relative abundance was calculated. Results
shown are representative of three independent experi-
ments performed in triplicate; statistical analysis for
significance was performed using a Student’s t-test.
in situ Hybridizations
Sectioned slides of unwounded fetal skin or wounded
fetal skin at 8 days post-injury were processed as
described [18], except using paraffin embedded sections.
Slides were deparaffinated using three xylene washes
and passed through an ethanol series, with a final wash
in 1× PBS. Slides were then processed as described [18],
using a 48 hour hybridization at 58°C. Slides were coun-
terstained with 0.1% Nuclear FastRed (Vector Labs, Bur-
lingame, CA) and mounted with aqueous ImmuMount
(ThermoFisher, Pittsburgh, PA) before photographing.
Results/Discussion
Our original PCR SSH screen [14] recovered multiple
fragments of gene sequence that are putatively over- or
under-expressed in healing fetal wounds compared to
unwounded fetal control tissues, but to which an exact
identity could not be assigned. To better characterize
these gene fragments, we interrogated a commercially
available rabbit multi-tissue Northern blot with
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identified in our screen. When the Northern blot was
hybridized with a probe directed against one gene pro-
duct from our screen, previously identified simply as
clone 11, a single major transcript of approximately 4
kb was detected in all rabbit adult tissues (Figure 1),
with highest levels of expression in the lungs, kidneys,
heart, ovaries, and testis, and lower levels of expression
in the pancreas.
We originally obtained only several hundred base pairs
of clone 11 sequence from our PCR SSH screen. We
then undertook both 5’ and 3’ RACE to obtain further
contiguous clone 11 sequence in the hopes of establish-
ing its identity. Using the Ensembl rabbit database and
BLAST, we determined that this expanded clone 11
sequence was derived from a rabbit genomic region
approximately 2.5 kb from the predicted gene Ero1L-
alpha. In humans, two transcripts of Ero1L-alpha are
known to exist; both contain a 1290 bp coding region
but differ in the length of their 3’ UTRs, with the longer
one approximating 5.3 kb in total length.
We therefore hypothesized that clone 11 in the rabbit
was the extended 3’ UTR form of Ero1L-alpha. Using
the rabbit predicted Ero1L-apha sequence from Ensembl
(ENSOCUG00000012632), we designed primers to
amplify (by RT-PCR) a large portion of the Ero1L-alpha
coding region from rabbit fetal control RNA. This
amplimer was subcloned and sequenced and matched
the predicted rabbit sequence from Ensembl, with 92%
sequence similarity to human Ero1L-alpha and 97% pre-
dicted protein similarity within the coding region of
Ero1L-alpha.
To confirm that the clone 11 sequence obtained from
our screen was the transcript of Ero1L-alpha containing
an extended 3’ UTR, we designed siRNA against the
clone 11 sequence and transfected rabbit adult fibro-
blasts with clone 11-specific siRNA, scrambled control
siRNA, or mock-transfected. After 48 hours, the RNA
purified from the various transfected fibroblast popula-
tions was reverse transcribed using a gene specific pri-
mer located within clone 11 sequence, and subjected to
real time PCR with probes specific either to clone 11 or
to the Ero1L-alpha coding region (Figure 2C). Due to
the use of clone 11 sequence as the primer for reverse
transcription, located in the extended 3’ UTR of the pre-
sumed Ero1L-alpha transcript isoform, the real time
PCR probe designed against the coding sequence of
Ero1L-alpha could only detect the extended 3’ UTR
transcript. We found that the siRNA against clone 11
significantly reduced detection of both clone 11-specific
and Ero1L-alpha coding sequence-specific real time PCR
probes. Neither scrambled siRNA nor mock transfection
resulted in any Ero1L-alpha message decrease, confirm-
ing that our clone 11 sequence is the 3’ terminus of the
extended 4 kb Ero1L-alpha transcript. As a further con-
firmation of these results, mouse NIH 3T3 cells were
transfected with siRNA against sequence corresponding
to clone 11, and demonstrated a similar reduction in
Ero1L-alpha coding transcript (data not shown).
Using a DIG-labelled probe derived from rabbit
Ero1L-alpha coding sequence, we sought to determine
which transcript isoforms are expressed in fetal and
adult skin tissues and fibroblasts, and to confirm that
Ero1L-alpha is expressed as two major transcripts in the
rabbit as was previously reported in humans. Using a
Northern blot prepared with total RNA isolated from
fetal and adult unwounded skin tissues and from fetal
and adult fibroblasts in culture, two transcripts of the
expected molecular weights (~1400 bp and ~ 4 kb) were
in fact observed in all samples (Figure 2B). Interestingly
and surprisingly, a third minor message isoform corre-
sponding to some 2.9 kb in length was also detected.
We have subsequently used 3’ RACE (using primers
within the Ero1L-alpha coding sequence) to amplify and
subclone the 3’ end of this isoform, and confirm that it
carries coding sequence identical to the other two tran-
scripts, but with an intermediate length 3’ UTR (data
not shown). A full schematic, showing the various
Ero1L-alpha message isoforms, together with locations
of probes and primers is depicted in Figure 2A.
Finally, we sought to determine if the long (4 kb) var-
iant of Ero1L-alpha is indeed increased after fetal
wounding, as would be expected from its survival in the
PCR SSH screen, and in which cell types this might be
evident. To address this question, fetal control and
wounded tissues were paraffin embedded, sectioned
onto slides, and used for in situ hybridization (Figure 3).
DIG-labeled RNA probes against the original clone 11
sequence were used to determine that healing fetal
wound tissue displayed a greater level of expression as
compared to control tissue from unwounded littermates
Figure 1 Clone 11 expression reveals a single 4 kb transcript
across most tissue types. Northern blot analysis of clone 11 using
adult total RNA, rabbit multi-tissue samples, and a non-radioactive
DIG RNA probe; the lanes represent 1) brain, 2) stomach, 3)
intestine, 4) colon, 5) liver, 6) lung, 7) kidney, 8) heart, 9) ovary, 10)
skeletal muscle, 11) spleen, 12) testes, 13) thymus, 14) skin, and 15)
pancreas. One predominant RNA transcript of approximately 4 kb
was detected in most rabbit adult tissues (Figure 1), with highest
expression in the lungs, kidneys, heart, ovaries, and testis and lowest
expression in skin and pancreas.
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locations of probes and primers employed. (B) Northern blot analysis of Ero1L-alpha using total RNA from rabbit fetal and adult skin and fibroblasts,
and a non-radioactive DIG RNA probe; the lanes represent 1) fetal skin, 2) adult skin, 3) rabbit fetal fibroblast, and 4) rabbit adult fibroblast. (C) Rabbit
adult fibroblasts were treated with siRNA against clone 11, as well as scrambled control siRNA and mock transfection. Extracted total RNA was then
used as a template for real time PCR to assay for expression of Ero1L-alpha coding sequence and clone 11 target sequence. Both Ero1L-alpha and
clone 11 were significantly reduced in siRNA-treated cells but not in control cells, indicating that clone 11 sequence represents Ero1L-alpha.
Figure 3 Increased expression of Ero1L-alpha in healing fetal wound. In situ hybridization using probe against clone 11 sequence reveals that
Ero1L-alpha is over-expressed in multiple cell types after fetal skin wounding (3B) compared to unwounded control skin (3A). (3C): healing fetal wound
tissue probed with a sense probe to clone 11, which would not be expected to hybridize to the target sequence. All images are at 5 × magnification.
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was observed when antisense probe was used on
w o u n d e df e t a lt i s s u e( F i g u r e3 B )c o m p a r e dt o
unwounded fetal control tissue (Figure 3A) Minimal
staining was observed in wounded tissue using sense
probe (Figure 3C) attesting that the assay is detecting
the correct RNA target. Interestingly, the 4 kb Ero1L-
alpha isoform appears to show increased expression in
almost all cell types within or adjacent to the zone of
healing injury. To ensure that our observed over-expres-
sion of Ero1L-alpha was not due to differences in RNA
levels due to sample preparation, a rabbit probe against
GAPDH was generated and tested in in situ hybridiza-
tion as well. This probe demonstrated no major differ-
ence in staining intensity between the fetal control and
wounded samples (data not shown), confirming that the
i n c r e a s e de x p r e s s i o ns e e ni nE r o 1 L - a l p h ai sas p e c i f i c
event.
Ero1L-alpha plays a major role in the oxidative protein
folding pathway in the endoplasmic reticulum, enabling
proteins to form disulfide bonds [19], and is specifically
up-regulated in response to hypoxic conditions [20]. It
has not been previously implicated in wound healing,
but it is not surprising that its expression may be ele-
vated in response to some hypoxic or ischemic stimulus
at the zone of injury. It is interesting that we recovered
only the 4 kb variant of Ero1L-alpha transcript in our
PCR SSH screen, with its attendant lengthy 3’ UTR.
Such UTR sequences have been found in other systems
to regulate gene expression through post-transcriptional
mechanisms [21-24], and it may be that a similar phe-
nomenon is occurring here. More study will be required
to fully explicate the specific functional and regulatory
significances of the multiple Ero1L-alpha isoforms we
have identified.
Conclusion
We conclude that one of the previously unidentified
gene fragments recovered in a PCR SSH screen examin-
ing fetal wound healing, clone 11, is a 4 kb isoform of
Ero1L-alpha, featuring an extended 3’ UTR sequence.
Ero1L-alpha is expressed as three distinct mRNA iso-
forms in fetal and adult skin tissues and fibroblasts,
including a novel 2.9 kb variant. The 4 kb isoform of
Ero1L-alpha shows increased expression in multiple cell
types after fetal integumentary wounding by in situ
hybridization.
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